Laimės terapija - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 45,559 | 57,235 | 53,336 | 63,062 | 68,296 | 86,815 | 71,173 | 57,672 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -3,895 | 2,779 | -2,958 | 12,251 | -15,256 | 1,303 | 3,285 | 574 |
| Equity | 314 | 3,093 | 135 | 12,386 | -2,869 | -1,566 | 1,720 | 2,294 |
| Liabilities | 10,167 | 10,615 | 14,291 | 5,769 | 25,063 | 17,197 | 8,380 | 5,434 |
| Non-current assets | 6,948 | 5,898 | 5,094 | 4,566 | 5,699 | 5,092 | 3,378 | 1,728 |
| Current assets | 3,533 | 7,796 | 9,317 | 13,572 | 16,488 | 10,537 | 6,720 | 6,000 |
| Total assets | 10,481 | 13,694 | 14,411 | 18,138 | 22,187 | 15,629 | 10,098 | 7,728 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 32,181 | 17,559 | 11,973 |
| Social insurance contributions | - | - | - | - | - | 3,383 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -16.6% | +25.6% | -6.8% | +18.2% | +8.3% | +27.1% | -18.0% | -19.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -37.2% | 20.3% | -20.5% | 67.5% | -68.8% | 8.3% | 32.5% | 7.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -1240.4% | 89.8% | -2191.1% | 98.9% | - | - | 191.0% | 25.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -8.5% | 4.9% | -5.5% | 19.4% | -22.3% | 1.5% | 4.6% | 1.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 32.4 | 3.4 | 105.9 | 0.5 | - | - | 4.9 | 2.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 16,080 | 20,201 | 13,914 | 18,457 | 21,014 | 26,045 | 28,469 | 27,683 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Laimės terapija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-02-19 | 2024-03-11 | 0.07 |
| 2024-01-23 | 2024-02-06 | 0.07 |
| 2023-11-16 | 2023-11-23 | 25.60 |
| 2022-04-19 | 2022-04-20 | 0.01 |
Laimės terapija - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Laimės terapija is: 20 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 19.84 |
| 2026-08-02 | 2026-08-31 | 19.53 |
| 2026-07-01 | 2026-08-01 | 19.22 |
| 2026-06-19 | 2026-06-30 | 19.1 |
| 2026-06-01 | 2026-06-18 | 18.92 |
| 2026-05-25 | 2026-05-31 | 18.83 |
| 2026-05-06 | 2026-05-24 | 18.61 |
| 2026-05-01 | 2026-05-05 | 31.02 |
| 2026-04-29 | 2026-04-30 | 31.0 |
| 2026-04-26 | 2026-04-28 | 30.95 |
| 2026-03-13 | 2026-03-18 | 37.28 |
| 2026-03-12 | 2026-03-12 | 62.78 |
| 2025-03-28 | 2025-03-31 | 764.97 |
| 2025-02-20 | 2025-02-25 | 0.02 |
| 2025-02-02 | 2025-02-14 | 0.02 |
| 2025-01-31 | 2025-01-31 | 36.2 |
| 2025-01-30 | 2025-01-30 | 36.22 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Laimes terapija, UAB (code 303216369) is a Private Limited Liability Company engaged in day spa, sauna and steam bath activities. In 2025, the company generated revenue of €57.7K and net profit of €574, resulting in a profit margin of 1.0%. Revenue declined by 19.0% year on year and by 33.6% over two years, indicating a clear downward sales trend compared with 2023 and 2024. Profitability remained positive, but much weaker than in 2024, when net profit reached €3.3K.
The balance sheet also contracted in 2025. Total assets fell to €7.7K from €10.1K a year earlier, while equity increased slightly to €2.3K and liabilities amounted to €5.4K. The equity ratio stood at 29.7%, and liabilities remained above equity, suggesting moderate leverage. Asset turnover was high relative to the asset base, reflecting efficient use of a small balance sheet. Revenue per employee was €28.8K, while profit per employee was €287, pointing to limited earnings generation in the latest year.
The balance sheet also contracted in 2025. Total assets fell to €7.7K from €10.1K a year earlier, while equity increased slightly to €2.3K and liabilities amounted to €5.4K. The equity ratio stood at 29.7%, and liabilities remained above equity, suggesting moderate leverage. Asset turnover was high relative to the asset base, reflecting efficient use of a small balance sheet. Revenue per employee was €28.8K, while profit per employee was €287, pointing to limited earnings generation in the latest year.